Supplementary Methods from Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide

Authors:
  • POPeter H. O'Donnell
    Peter H. O'Donnell
  • SKSanja Karovic
    Sanja Karovic
  • TKTheodore G. Karrison
    Theodore G. Karrison
  • LJLinda Janisch
    Linda Janisch
  • MLMatthew R. Levine
    Matthew R. Levine
  • PHPamela J. Harris
    Pamela J. Harris
  • BPBlase N. Polite
    Blase N. Polite
  • ECEzra E.W. Cohen
    Ezra E.W. Cohen
  • GFGini F. Fleming
    Gini F. Fleming
  • MRMark J. Ratain
    Mark J. Ratain
  • MMMichael L. Maitland
    Michael L. Maitland

Abstract
Supplementary Methods from Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide